BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure
22 mars 2022 08h30 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Eargo Inc. Investors: Company Investigated by the Portnoy Law Firm
23 sept. 2021 13h23 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 23, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Eargo, Inc. ("Eargo" or the...